Breast Cancer Flashcards
Breast cancer is the most common type of cancer globally.
a. true
b. false
a. true
What typeof gene is p53?
tumor suppressor gene
The normal BRCA gene helps __ repair
DNA
tumor suppressor gene
Age >= ___ is a risk factor for breast cancer
50
Early menarche at <= __ years old is a risk factor for breast cancer
12
Endogenous estrogen exposure:
- early menarche (<=12)
- late menopause (>=55)
- late 1st pregnancy (> 30)
Being HR __ is a poor prognostic factor
a. positive
b. negative
a. positive
Biomarker testing is a NCCN strong consideration for tumor size > __ cm and risk score determines therapy decisions`
0.5
__ is highly recommended
a. breast self exam
b. breast self awareness
b. breast self awareness
Which guideline does not recommend clinical breast exam?
a. ACS
b. USPSTF
c. NCCN
select two
a, b
NCCN:
- age 25-39 every 1-3 years
- age >=40 annually
NCCN recommends mammography annually for what age?
> = 40
___ is used to assess extent of disease
a. ultrasound
b. MRI
b. MRI
assess extent of disease
evaluate abnormalities found on other diagnostic tools
__ is used for pathology assessment
a. ultrasound
b. MRI
c. biopsy
c. biopsy
Give chemotherapy in breast cancer with tumors of what size?
> 1cm
What is general treatment for HR+, LN-, HER2- with RS < 26?
adjuvant endocrine therapy
What is general treatment for HR+, LN-, HER2- with RS >26
adjuvant endocrine therapy +/- chemo
What is general treatment for HR+, LN-, HER2+ with T<=0.5 or T 0.6-1cm?
T <=0.5cm: consider adjuvant endocrine therapy +/- chemo + trastuzamab
T 0.6-1cm: adjuvant endocrine therapy +/- chemo +/- trastuzamab
What is general treatment for HR+, LN-, HER2+ with T > 1cm?
adjuvant endocrine therapy + chemo + trastuzamab
What mab is +/- with LN positive?
pertuzumab
Taxanes cause what AE?
peripheral neuropathy
What is the general treatment of choice for stage I or II adjuvant chemotherapy for breast cancer?
taxane +/- anthracycline
doxorubicin +
cyclophosphamide for 4 cycles then weekly paclitaxel for 12 cycles
docetaxel + cyclophosphamide
Which class of endocrine therapy has increased CYP2D6 inhibitor interactions?
a. LHRH agonists
b. SERMs
b. SERMs
3 LHRH agonists:
goserelin
leuprolide
triptorelin
which class of endocrine therapy causes bone loss with long term use?
a. LHRH agonists
b. SERMs
a. LHRH agonists
What is the only LHRH agonist approved for breast cancer?
goserelin